SOFIA FUND INVESTS IN KENZEN
September 5, 2018 (Minneapolis) – Sofia Fund, a leading angel investment group focused on high-growth, women-led early stage companies, today announced its most recent investment in Kenzen, a San Francisco-based health analytics platform focused on predicting and preventing avoidable health conditions. Kenzen is the maker of Kenzen Patch™, a wearable vital sign and sweat-analysis system that continuously monitors parameters needed to detect heat-related injuries in workers and at-risk individuals.
The Sofia Fund investment brings Kenzen’s total amount raised to $7 million, which will be used for product enhancements and acceleration of market adoption of the Kenzen Predictive Workforce Solution. The Kenzen platform uses real-time biosensor data and predictive models to detect heat-related health events before they occur. Patches on workers monitor sweat rate, heart rate, body temperature and active time in high-risk and extreme environments. The solution is currently gaining substantial traction globally with paid pilot projects in the U.S., the Middle East and Japan.
“Kenzen is exactly the type of company Sofia Fund looks for – a company of women founders and leaders in science and tech who create products that truly have an impact in the marketplace,” said Joy Lindsay, Sofia Fund partner. “Kenzen technology is at the intersection of Internet of Things (IOT) wearables, sensors and data analytics, all areas of great promise for product innovation. With the diversity and solid structure of its leadership team, we believe Kenzen is set for up for success in this exciting space.”
Kenzen is the second company Sofia Fund has added to its portfolio this year. Sofia Fund also invested in Joylux, a femtech company that creates innovative health solutions targeting the enormous but underserved female intimate care market. Sofia Fund has also made follow-on investments in two of its existing portfolio companies.
“An infusion from an investor like Sofia Fund is particularly meaningful to our team,” said Jim McDonnell, who became CEO of Kenzen after the passing of co-founder Dr. Sonia Sousa. “Sonia always recognized the power of diverse teams to propel businesses to success. Like the partners at Sofia Fund, she was an inspiration to many women founders and entrepreneurs”.
Kenzen is an innovator in personal health monitoring and predictive analytics designed to empower its users in the field of precision health and safety. With real-time sweat biomarker analysis, the award-winning Kenzen Patch continuously measures sweat, vital signs and a key set of biometrics. Kenzen helps companies, teams and individuals to reduce injuries, optimize their health, and prevent against adverse health conditions by delivering highly personalized insights and notifications. Learn more at https://kenzen.com/
About Sofia Fund
Sofia Fund invests in and grows exceptional women-led companies to maximize returns for investors by bringing its portfolio companies successfully to profitable exits. Sofia Fund uses a rigorous process for selecting and investing in high-growth, technology-driven opportunities. Its team of professional women angel investors actively manages and supports its portfolio businesses, leveraging deep expertise and broad networks to help women entrepreneurs achieve success. Its investment team has invested more than $10 million in 50 companies to date. For more information about what makes a business fundable, see http://sofiafund.com/angels-tell-the-truth-what-makes-a-new-company-fundable/. For more information about Sofia Fund, visit www.sofiafund.com.
This release originally appeared on the Sofia Fund website.